May 2026 — Amiens, France
Glyx Therapeutics is a laureate of the French Tech Emergence Deeptech grant, awarded with the support of the Hauts-de-France Region, Amiens Métropole and Bpifrance. The grant amounts to €90,000.
What it will allow
- Accelerate the development of our research work
- Strengthen our innovation capacity
- Advance high-impact projects against Alzheimer’s disease and rare tauopathies
We sincerely thank the Hauts-de-France Region, Amiens Métropole and Bpifrance for their trust and commitment, which help turn our scientific advances into concrete solutions for patients and their families.
Learn more about our pipeline, our research on tauopathies and Alzheimer’s disease, or about Glyx Therapeutics.
